NCT07394075
Clinical Decision Support With Continuous Glucose Monitoring Data for Managing Type 2 Diabetes
Enrolling by Invitation
Not specifiedAges 18–75ObservationalHealthPartners InstituteInvestigator-initiated
~150 participants
Updated 2026-07-10 on ClinicalTrials.gov
What's tested:Continuous Glucose Monitoring Clinical Decision Support
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in % glucose management indicator (GMI%)
Measured over From baseline to 6 months
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Thomas Martens, MD · PRINCIPAL_INVESTIGATOR · HealthPartners Institute, International Diabetes Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Type 2 diabetes
A1c greater than 7.5%
On insulin therapy
Use CGM for glycemic monitoring
Exclusion
Pregnancy
Use of insulin pump or automated insulin delivery system
Active cancer (other than nonmelanoma skin cancer or low-grade prostate cancer being followed with observation)
Cognitive barriers requiring assistance of a surrogate or caregiver for insulin management
What this trial measures
- Change in % glucose management indicator (GMI%)From baseline to 6 months